Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland.
ICF, Fairfax, Virginia.
Cancer Prev Res (Phila). 2022 May 3;15(5):273-278. doi: 10.1158/1940-6207.CAPR-21-0599.
The Division of Cancer Prevention in the NCI sponsored a Roundtable with primary care providers (PCP) to determine barriers for integrating cancer prevention within primary care and discuss potential opportunities to overcome these barriers. The goals were to: (i) assess the cancer risk assessment tools available to PCPs; (ii) gather information on use of cancer prevention resources; and (iii) understand the needs of PCPs to facilitate the implementation of cancer prevention interventions beyond routine screening and interventions. The Roundtable discussion focused on challenges and potential research opportunities related to: (i) cancer risk assessment and management of high-risk individuals; (ii) cancer prevention interventions for risk reduction; (iii) electronic health records/electronic medical records; and (iv) patient engagement and information dissemination. Time constraints and inconsistent/evolving clinical guidelines are major barriers to effective implementation of cancer prevention within primary care. Social determinants of health are important factors that influence patients' adoption of recommended preventive interventions. Research is needed to determine the best means for implementation of cancer prevention across various communities and clinical settings. Additional studies are needed to develop tools that can help providers collect clinical data that can enable them to assess patients' cancer risk and implement appropriate preventive interventions.
美国国立癌症研究所（NCI）癌症预防司举办了一次初级保健提供者（PCP）圆桌会议，以确定在初级保健中整合癌症预防的障碍，并讨论克服这些障碍的潜在机会。目标是：（i）评估 PCP 可用的癌症风险评估工具；（ii）收集癌症预防资源使用情况的信息；（iii）了解 PCP 的需求，以促进实施超越常规筛查和干预的癌症预防干预措施。圆桌会议讨论的重点是与以下方面相关的挑战和潜在研究机会：（i）癌症风险评估和高危个体的管理；（ii）降低风险的癌症预防干预措施；（iii）电子健康记录/电子病历；（iv）患者参与和信息传播。时间限制和不一致/不断变化的临床指南是在初级保健中有效实施癌症预防的主要障碍。健康的社会决定因素是影响患者接受推荐预防干预措施的重要因素。需要研究确定在不同社区和临床环境中实施癌症预防的最佳方法。需要进一步的研究来开发工具，帮助提供者收集临床数据，使他们能够评估患者的癌症风险并实施适当的预防干预措施。
